HomeStrategyA $435 Million Bet on ‘Reversing Aging’ Strategy A $435 Million Bet on ‘Reversing Aging’ Strategy June 7, 2026 0 120 FacebookXPinterestWhatsApp Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver. FacebookXPinterestWhatsApp Cody Previous articleDell sharpens data protection strategy as AI reshapes cyber resilienceNext articleLayoffs don’t have to feel inhumane RELATED ARTICLES Strategy Want to Protect Against Cognitive Decline? A New Study Says to Change This 1 Eating Habit Strategy Netflix faces cease-and-desist over controversial scene in new documentary Strategy Major U.S. firms spent $600 million on perks for execs Strategy Lawyers, teachers, and students face consequences when they use AI to do their jobs. What about politicians? Must Read AMD calls its shot, but the real race is engineering velocity Tech Ilya Sutskever’s Safe Superintelligence gets access to Nvidia’s Vera Rubin platform Tech Chinese memory maker CXMT jumps 460%+ in first day of trading Tech Enigma raises $71M to develop foundation models for robots Tech Affiliated scores $74M construction loan for Fort Lauderdale Live Local project as lending thaws Real Estate